Received: 5 June 2020
Accepted: 4 February 2021
First Online: 16 April 2021
Ethics approval and consent to participate
: Queen Mary, University of London (QMUL) approved this study. QMREC2009/22 – A prospective study to assess the effectiveness of prolotherapy in the management of unresponsive and painful MTSS. All subjects provided written informed consent before participating in the study.
: Participants and QMUL were aware that findings will be disseminated at conferences and results will be published.
: None declared. The authors disclose no conflict or competing of interest, they did not receive any financial payments or other benefits from any commercial entity related to the subject of this article. No outside source of funds was involved in the preparation of or editing of the manuscript.